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(57) ABSTRACT
A Multimodality Brain Mapping System (MBMS), compris-
ing one or more scopes (e.g., microscopes or endoscopes)
coupled to one or more processors, wherein the one or more
processors obtain training data from one or more first images
and/or first data, wherein one or more abnormal regions and
one or more normal regions are identified; receive a second
image captured by one or more of the scopes at a later time
than the one or more first images and/or first data and/or
captured using a different imaging technique; and generate,
using machine learning trained using the training data, one
or more viewable indicators identifying one or abnormalities
in the second image, wherein the one or more viewable
indicators are generated in real time as the second image is
formed. One or more of the scopes display the one or more
viewable indicators on the second image.
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MULTI MODALITY BRAIN MAPPING
SYSTEM (MBMS) USING ARTIFICIAL
INTELLIGENCE AND PATTERN
RECOGNITION
CROSS-REFERENCE TO RELATED
APPLICATIONS
This application claims the benefit under 35 U.S.C. Sec-
tion 119(e) of the following co-pending and commonly-
assigned U.S. provisional patent application(s), which is/are
incorporated by reference herein:
Provisional Application Ser. No. 62/031,719, filed on Jul.
31, 2014, by Shouleh Nikzad and Babak Kateb, entitled
"SMART MICROSCOPE AND ENDOSCOPES USING
MULTIMODAL IMAGING, ARTIFICIAL INTELLI-
GENCE AND PATTERN RECOGNITION,".
STATEMENT REGARDING FEDERALLY
SPONSORED RESEARCH AND
DEVELOPMENT
The invention described herein was made in the perfor-
mance of work under a NASA contract, and is subject to the
provisions of Public Law 96-517 (35 USC 202) in which the
Contractor has elected to retain title.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to a medical
imaging technique.
2. Description of the Related Art
(Note: This application references a number of different
publications as indicated throughout the specification by
reference numbers enclosed in brackets, e.g., [x]. A list of
these different publications ordered according to these ref-
erence numbers can be found below in the section entitled
"References." Each of these publications is incorporated by
reference herein.)
The incidence of brain tumors, including metastasis, is on
the rise. Despite considerable advances in diagnosis and
treatment, the survival rate of patients with malignant brain
tumors has not significantly improved. The mortality from
malignant brain tumors remains high, as the median survival
rate is 12 to 18 months in patients with glioblastoma and 41
months in patients with anaplastic astrocytomas [60, 88,
108, 114]. Currently, brain tumors are treated through che-
motherapy, immunotherapy and surgery. Surgical resection
followed by radiotherapy and chemotherapy offers a sur-
vival benefit, particularly when resection is complete [80,
86, 88, 94, 100]. Thus, surgical resection provides signifi-
cant benefit should surgeons achieve near complete resec-
tion, and therefore the completeness of removal of the tumor
is a major factor in improving survival and quality of life in
tumor patients.
Although many advances have been made in the field of
brain imaging in the last decades, brain shift, also known as
post-imaging brain distortion, often makes intraoperative
delineation of the tumors difficult, as its preoperative imag-
ing can no longer be fully relied on [74, 77, 90, 98].
Moreover, it is difficult to distinguish brain tumors from
normal surrounding tissue if they exhibit an infiltrative
nature, which makes it virtually impossible to achieve near
total resection.
Therefore, there is a great need for development of new
imaging techniques and integration of multimodality imag-
2
ing (pre-, intra-, and post-operative imaging, and endoscopic
imaging) with advanced mathematical pattern recognition/
predictive modeling as well as parallel computing and
supercomputing for data analysis. One or more embodi-
5 ments of the invention can satisfy this need by integrating
various imaging technologies (including intra-operative
brain imaging/mapping technologies such as thermography,
Ultraviolet (UV) imaging, Magnetic Resonance Imaging
(MRI), and Computed Tomography (CT)) with an intelligent
10 system (including machine learning), to provide a real time
intra-operative tool that delineates abnormal cells from
normal cells.
SUMMARY OF THE INVENTION
15
One or more embodiments of the invention disclose a
method and apparatus comprising machine learning that
uses shared data and/or predictive modeling to identify
and/or predict abnormal growth in (e.g., microscope/endo-
20 scope) images. The system can comprise a smart microscope
and/or endoscope using multimodal imaging, artificial intel-
ligence (AI), and pattern recognition. A system according to
one or more embodiments can comprise one or more scopes
(e.g., including an optical scope) coupled to one or more
25 processors, wherein the one or more processors obtain
training data from one or more first images, wherein one or
more abnormal regions and one or more normal regions are
identified; receive a second image (e.g., an optical image)
captured by one or more of the scopes at a later time than the
30 one or more first images and/or captured using a different
imaging technique; and generate, using machine learning
trained using the training data, one or more viewable indi-
cators identifying one or more abnormalities in the second
image, wherein the one or more viewable indicators are
35 generated in real time as the second image is formed. One
or more of the scopes can display the one or more viewable
indicators on the second image. The one or more scopes can
comprise, but are not limited to, one or more microscopes,
one or more endoscopes, one or more cameras, and/or one
40 or more instruments used to image (e.g., using optical or
other wavelengths, as used in medical imaging systems).
The system can comprise a Multimodality Brain Mapping
System (MBMS) (e.g., obtaining IR, UV, MRI, CT, Ultra-
sound, or other images, and/or molecular data, cellular data,
45 genomic data, and patient medical data).
One or more of the processors can comprise one or more
multi-modality image processors that register at least two of
the first images obtained from biopsy, Infrared Imaging,
Ultraviolet Imaging, Diffusion Tensor Imaging (DTI), Com-
50 puted Tomography (CT), Magnetic Resonance Imaging
(MRI), Brain Mapping Ultrasound, Generic DNA sequenc-
ing, optical imaging, and Functional MRI (FMRI), to form
a registered image. One or more of the processors can
receive input that identifies or marks the one or more
55 abnormal and normal regions in the registered image.
One or more first images can comprise a pre-operative
image and/or an intra-operative image and/or a post opera-
tive image of one or more patients.
Cloud and/or parallel computing can be used to connect
60 scopes so that the scopes can access, share, and learn from
the data obtained from different scopes. A multi-central
parallel computing and machine learning apparatus can be
provided. For example, the scopes can comprise one or more
first scopes capturing the one or more first images of one or
65 more patients and a second scope capturing the second
image of a different patient. The system can further comprise
a cloud and/or supercomputing/parallel computing system
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wherein the training data obtained from the one or more first
images captured in the one or more first scopes is shared so
that the machine learning learns from the training data to
identify the one or more abnormalities in the second image
of the different patient.
The processors can predict growth of the one or more
abnormalities in the second image from predictive modeling
of, and/or pattern recognition in, the training data. One or
more of the processors can represent the abnormal regions
with first feature vectors defining first coordinates in a
feature space; represent the normal regions with second
feature vectors defining second coordinates in the feature
space, wherein the feature space is selected such that at least
some of the first coordinates and at least some of the second
coordinates are on opposite sides of a hyper-plane in the
feature space; map an image region of the second image to
one or more image coordinates in the feature space; classify
one or more of the image coordinates as one or more
abnormal coordinates depending on one or more factors. The
factors can include which side of the hyper-plane the one or
more image coordinates lie; and/or proximity of the one or
more image coordinates to the first coordinates and/or the
hyper-plane. The processors can indicate the image region as
an abnormal image region if the image region is mapped to
one or more of the abnormal coordinates according to the
map. The one or more processors can implement a support
vector machine.
One or more embodiments of the invention can be applied
during surgical procedures. Since real time intra-operative
mapping of brain cancer and epileptic areas is critical in
removing the abnormal tissue and leaving the healthy tissue
intact, there is a great need for the multimodality intra-
operative optical imaging technology according to one or
more embodiments of the invention. One or more embodi-
ments of the invention can be implemented in a microscope/
endoscope and focus on intra-operative detection of diseased
tissue in real time using multimodality imaging data while
helping the micro scope/endoscope train itself (become more
intelligent) and use pattern recognition software to predict
the pattern of abnormal (e.g., cancer) growth.
BRIEF DESCRIPTION OF THE DRAWINGS
Referring now to the drawings in which like reference
numbers represent corresponding parts throughout:
FIG. 1A-FIG. 1E illustrate an imaging system that uses
machine learning, according to one or more embodiments of
the invention;
FIG. 2 illustrates a method of imaging according to one or
more embodiments of the invention;
FIG. 3 is a block diagram illustrating an auto-delineation
process in a training phase, according to one or more
embodiments of the invention;
FIG. 4 is a block diagram illustrating an auto-delineation
process in an operating phase, according to one or more
embodiments of the invention;
FIG. 5 is an exemplary hardware and software environ-
ment used to implement one or more embodiments of the
invention;
FIG. 6 schematically illustrates a typical distributed com-
puter system, according to one or more embodiments of the
invention;
FIG. 7 is a flowchart illustrating a method of identifying
abnormal cells, according to one or more embodiments of
the invention;
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FIG. 8 is a flowchart illustrating a method of classifying
abnormal cells, according to one or more embodiments of
the invention; and
FIG. 9 is a schematic of a feature space according to one
5 or more embodiments of the invention.
DETAILED DESCRIPTION OF THE
PREFERRED EMBODIMENTS
10 In the following description, reference is made to the
accompanying drawings which form a part hereof, and
which is shown, by way of illustration, several embodiments
of the present invention. It is understood that other embodi-
ments may be utilized and structural changes may be made
15 without departing from the scope of the present invention.
One or more embodiments of the invention integrate
various imaging technologies to provide a real time intra-
operative tool that delineates abnormal cells from normal
cells. Real time data analysis using artificial intelligence
20 (AI) and mathematical modeling can be used for pattern
recognition so that in a crowded imaging scene, areas of
interest can be identified, zoomed in and used during sur-
gery.
One or more embodiments of the invention provide a
25 smart micro scope/endoscope similar to current intra-opera-
tive microscopes in terms of the visible optics, but further
comprising an enhanced multispectral array enabling analy-
sis of the different light spectrums (in real time), which
could be analyzed by mathematical/predictive modeling
30 systems using computing systems. The data obtained from
the different light spectrums can be integrated with pre-
operative images (obtained from Computed Tomography
(CT), UV, IR, Magnetic Resonance Imaging (MRI), Ultra-
sound, etc.,) and pathology report(s) (e.g., histopathology
35 report(s)). The artificial intelligence part of the microscope
helps the technology to learn from each case and teach itself
using the imaging (pre-, intra-, as well as post-operative
imaging), while using mathematical modeling and/or
method(s)/system(s) to predict the pattern of abnormal/
40 epileptic region growth.
In one or more embodiments, the multi-modality imaging
system includes visualization, registration, and integration
of Infrared Thermal Imaging (ITI), UV, visible images, MRI,
and biopsy, to provide observers/operators (e.g., neurosur-
45 geons) with a more comprehensive set of data, thus facili-
tating a more objective decision-making process. The imag-
ing system can be enhanced by auto-delineating tumor
resection margins using a semi-supervised learning method/
system. The semi-supervised learning method/system can be
50 trained on a manually delineated reference dataset prepared
by experts, and then applied in real-time to intraoperative
and visual imagery, to (semi-)automatically generate delin-
eations of the resection margins. Giving such valuable
real-time information to the surgeon/observer can signifi-
55 cantly improve the surgical accuracy and thus contribute
significantly to the survival and quality of life of patients
with malignant brain tumors (or other tumors).
FIG. 1A-FIG. 1E illustrate a method and system for
imaging using machine learning, according to one or more
60 embodiments of the invention.
FIG. 1A illustrates capturing one or more pre-operation
images (e.g., multi-modality imaging 100) of tissue (e.g., the
brain) in a patient 102 using one or more imaging systems
104. The imaging system(s) 104 can include one or more of
65 the following: biopsy to obtain a biopsy image 106a, Dif-
fusion Tensor Imaging (DTI) to obtain DTI image 106b, CT
imaging to obtain a CT image 106c, MRI to obtain an MRI
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image 106d, Brain Mapping Ultrasound to obtain a Brain
Mapping Ultrasound image 106e, molecular and cellular/
genomic data 106f, and Functional MRI (FMRI) to obtain an
FMRI image 106g. Thus, multi-modality imaging can be
performed.
FIG. 1B represents capturing one or more intra-operation
images of the tissue 108 (e.g., the brain, e.g., the same tissue
as imaged in FIG. 1A, or different tissue as compared to the
tissue imaged in FIG. 1A) including a diseased/abnormal
region 110 (e.g., a cancerous tumor) using one or more
imaging systems/cameras 112. The patient in FIG. 1B can be
the same patient as in FIG. 1A, or a different patient. The
imaging system(s) 112 can include one or more of the
following: DTI to obtain a DTI image 112a, Infrared (IR)
imaging to obtain an IR image 112b, Ultraviolet (UV)
imaging to obtain a UV image 112c, optical imaging to
obtain an optical image 112d, and brain ultrasound to obtain
a brain ultrasound image 112e. Thus, multi-modality imag-
ing can be performed and data could be obtained and
analyzed using a computing system.
FIG. 1C represents capturing one or more post-operation
images (e.g., post previous surgery, post-current surgery) of
tissue (e.g., the brain, e.g., the same tissue as imaged in FIG.
1A, or different tissue as compared to the tissue imaged in
FIG. 1A and FIG. 113) in the patient 102 using one or more
imaging systems 114. The patient 102 can be the same as the
patient(s) in FIG. 1A or FIG. 113, or a different patient. The
imaging system(s) 114 can include one or more of the
following: DTI obtaining DTI image 116a, CT obtaining CT
image 116b, MRI obtaining MRI image 116c, Brain Map-
ping Ultrasound obtaining Brain Mapping Ultrasound image
116d, Generic DNA sequencing obtaining generic DNA
sequencing image 116e, and FMRI obtaining FMRI image
116f, and biopsy obtaining biopsy image 116g. Thus, multi-
modality imaging can be performed.
FIG. 1D represents performing a classification using a
machine learning system/classifier 118, wherein one or more
of the pre-operation images 106a-g, intra-operation images
112a-e, and post operation images 116a-g are combined/
registered (e.g., using image processing) and are used to
train the machine learning system 118 operating in a training
mode 120, thereby obtaining a trained support vector
machine 122. The trained support vector machine 122 used
in an operation mode 124 classifies tumor and non-tumor
tissues in microscope image data and outputs the classifi-
cation information 126 (e.g., so that tumor regions in the
images 112a-112e obtained during the intra-operation imag-
ing illustrated in FIG. 1B can be identified). The machine
learning system 118 can use predictive modeling to identify/
predict a pattern of abnormal (e.g., cancer) growth in images
captured by microscopes.
FIG. 1E illustrates improving the machine learning tech-
nology. For example, the machine learning 118 can further
use Hidden Markov, Adaptive Boosting (ADABOOST), or
other machine learning technologies 128 to obtain more
accurate results 130 for the classification 126 of the tumor
and non-tumor tissues during the operation mode 124. The
results 130 can be compared 132 to post surgical expert
delineations 134 of the abnormal regions in the tissue (e.g.,
by a medical care provider, using images obtained using the
imaging in FIG. 1C) to evaluate accuracy 136 of the results
130. The expert delineations can be provided for the same
regions of tissue as classified in 126, or for different tissues
obtained from different patients. The evaluation 136 can
comprise generating receiver operating characteristic (ROC)
curves and comparing the ROC curves for different estima-
tors. The evaluation 136 can comprise performing cross
6
validation. The results of the accuracy evaluation 136 can be
used to obtain an improved machine learning technology
138 so that more accurate classification 126 of diseased
regions (e.g., in the intra-operation images 112a-e) by the
5 machine learning is achieved.
Current micro scope/endo scope technologies only rely on
high resolution visible light with potential integration of few
intraoperative imaging technologies. The technology
according to one or more embodiments of the invention, on
io the other hand, can use and combine multiple photonics
imaging technologies, standard pre-operative imaging such
as MRI, CT, PET, and ultrasound, biopsy, and patient
record(s) with real time neurophotonic data, and link the
data obtained using these technologies to/using a machine
15 learning technology, as well as mathematical software,
which could calculate and predict patterns.
Surgical Setup
In one embodiment, the usual surgical pre-planning pro-
cedure does not need to be modified, although (e.g., 60
20 seconds of) thermal images (as an example of one of the
modalities) pre-intra and post-tumor resection can be
recorded if necessary. A camera/intraoperative imaging sys-
tem could be used independently and or used as an inte-
grated part of the intraoperative microscope/endoscope,
25 thereby allowing convenient optical and non-optical (e.g.,
cellular, molecular, and genomic) access to the operative
field. The camera, except for the lens, can be covered with
conventional surgical draping to maintain the sterility of the
operative site. To reach the proper operating temperature of
30 the detector, an electrical cooler within the camera can be
activated (e.g., 20 minutes before taking measurements).
The surgical lights near the operative site can be redirected
from the surgical field during multi modality measurements
(i.e., infrared, UV, etc.), so that they do not affect the infrared
35 measured heat pattern. Sequential digital images can also be
obtained during surgery.
Data Acquisition
FIG. 2 illustrates a process of data acquisition, comprising
steps 200-210, according to one or more embodiments of the
40 invention.
Blocks 200 and 210 represent capturing one or more
images (e.g., using a camera 212, e.g., IR or UV camera and
or other multi-modal imaging systems/imaging as illustrated
in FIG. 113) and visual images 214 (e.g., using a head
45 mounted display (HMD), such as glasses, worn by a sur-
geon/surgical loops), respectively, after the surgical site has
been exposed (e.g., when the craniotomy is finished and the
brain 216 of the patient 218 has been exposed). Several
images and image/data sets can be obtained as the surgeons)
50 (e.g., neurosurgeon(s)) proceed with the dissection of the
tissue (e.g., brain abnormalities such as brain tumor, Arte-
riovenous malformation (AVM), epileptic area(s), etc.).
Block 202 represents identifying the abnormal region
(e.g., tumor, cancer, an epileptic region treated by intraop-
55 erative epilepsy surgery, Arteriovenous malformation
(AVM)) 220 in the image 222 captured by camera 212. The
step can include human (e.g., pathologist, neurosurgeon) or
Al expert delineations delineating the tumor 220 in the
image 222. The annotation, delineations, and marking (e.g.,
60 of areas for biopsies) can be entered and accessed from a
database.
Block 204 represents image processing the captured
image 222 using a computer 224 (e.g., in an image processor
of the computer 224) to form a processed image 226. The
65 image processing can comprise image registration.
Block 206 represents enhancing/manipulating the pro-
cessed image 226 via image processing (in an image pro-
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cessor), e.g., to improve brightness, color, contrast, etc., to
form an enhanced image 228. In one or more embodiments,
a Red Hat LinuxTM software package can be used for the
image processing.
Block 208 represents performing auto-delineation 230 of 5
the tumor area (e.g., in a machine learning processor), using
a supervised learning technique trained using the enhanced
image 226 comprising the Al expert delineations (e.g.,
accessed from the database) with possibility of override by
human operator. The automatic delineation can be per- io
formed by a computer/AI system. New data can also be
integrated into the supervised training delineation tool.
Block 210 represents enhancing the surgeon's view 216
using the semi-transparent HMD that overlays the auto-
delineation 230 and classification of the abnormality 232 on 15
the surgeon's view 214.
Thermal imaging can also be performed after completion
of the surgical procedure. For example, when the tumor is
believed to have been completely removed, Intraoperative
Brain Mapping (i.e., thermal, UV imaging, and/or other 20
imaging) of the cavity can be performed, e.g., for 60-120
seconds, followed by auto-delineation based on the result.
For those areas suspected of harboring residual tumor tissue,
several options can be exercised, including, but not limited
to, (1) resecting and separately analyzing those residual 25
areas that correspond to abnormal tissue, (2) performing
biopsy only on those volumes felt to represent a tumor by
temperature criteria alone, and (3) abstaining from sampling
those areas suspected of being tumor, but residing in critical
brain areas, so as not to jeopardize the safety of the surgical 30
procedure.
Multimodality Intraoperative Brain Mapping (i.e., ther-
mal, UV, and/or other images or data) can be compared with
the stereotactic images, with pathology reports generated
throughout all the phases of the operative procedure, and 35
with pre-intra and post-operative MRI and CT scans and
other datasets (e.g., cellular, molecular, and genomic data).
In one or more embodiments, IR images can be captured
using a low-resolution Thermal imaging technologies. For
example, the paper published by Kateb et. al [123] describes 40
a thermal imaging system (with a 320x240 pixel size, a
thermal response in the IR wavelength band of 7.5-13.5
micrometers, and having a sensitivity of less than 0.1° C.).
The auto-delineation system according to one or more
embodiments of the invention can be rapidly implemented 45
using thermal image(s) captured in the thermal imaging
system described in [123] or an advanced NASA/7PL IR
system. In one or more embodiments, the thermal image
data from a thermal camera (e.g., a thermal imaging system
that is currently commercially available) can be accessed via 50
its firewire interface, the IR imagery can be stored on a
computer interfacing with the camera, and/or software can
be used to capture and subsequently display the IR camera
imagery on the computer. In one or more embodiments, a
Red Hat Linux OSTM and software package can be used to 55
interface, access, and capture the IR image from the thermal
imaging system described in [123]. However, one or more
embodiments of the invention are not limited to thermal (IR)
imaging systems, and other imaging systems (e.g., UV) or
data (cellular, molecular, and genomic) can be used for 60
MBMS.
In one or more embodiments, the steps 200-210 can be
implemented in multiple computers and/or using multiple
imaging systems, each performing one or more of the steps
200-210 (e.g., using cloud computing). Results from each of 65
the computers and image systems can be combined to
improve identification of the abnormality.
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System Functionality
A system according to one or more embodiments of the
invention can provide the following functionalities.
First, the system can integrate several different image
modalities, including visible light, Infrared (IR), Ultraviolet
(UV), and Magnetic Resonance Imaging (MRI) scans (pre-
operative as well as intra-operative), and data sets including
molecular and genomic/biopsy data (preoperative as well as
intra-operative), if available, biopsy markers, and intra-
operative ultrasound, in order to show a single 2D view of
the surgical field combining the information from the mul-
tiple image sources. In one or more embodiments, this
integration is achieved using a multimodality image regis-
tration module. Therefore, the 2D image will be transformed
into a 3D image and 4D (mathematical predictive modeling)
can be added to the Yd dimension.
Second, the system's view or display can include sugges-
tive contours of the remaining tumor tissue, as computed by
a tumor auto-delineation engine. An operator or observer
(e.g., neurosurgeon) can see these contours in real time, as
an overlay on the IR and visual images. The tissue indicated
as a residual tumor by the auto-delineation method/system
according to one or more embodiments can be inspected and
biopsy markers can be extracted from those sites. The biopsy
markers can be used for further validation of the delineation
engine/resection margin, and later added to a reference
database for further refinement of the auto-delineation
method/system.
These two modules are discussed in further detail in the
following sections.
A. Multimodality Image Registration
Images from different modalities, as well as biopsy mark-
ers (molecular/cellular genomic data), are typically in dif-
ferent coordinate systems. Thus, in one or more embodi-
ments, they need to be co-registered with each other to align
the images pixel-wise. To this end, the first step is camera
calibration and data acquisition.
Camera Calibration According to One or More Embodi-
ments
Calibration of the camera (i.e., IR or UV modality) is the
process of finding the parameters of the camera, i.e., posi-
tion, orientation, focal length, etc., that produced a given
Multimodality Intraoperative Brain Mapping (e.g., IR
image, UV image, and/or other images and/or cellular,
molecular, genomic data). In this step, the experimental
setup can be geometrically modeled by a 3x4 matrix which
transforms two dimensional (21)) screen coordinates to three
dimensional (31)) coordinates as well as a four dimensional
(41)) mathematical predictive modeling system. This trans-
formation corrects for effects of perspective projection and
camera focal length in the Multimodality Intraoperative
Brain Mapping (e.g., IR image, UV image, and/or other
images or data), and thus helps with registration of MRI, UV
and IR images of the tissue (e.g., patient brain). In addition,
biopsy markers can be registered to the MRI and IR images.
In this way, biopsy markers, if available, can be imported to
improve the auto-delineation. Furthermore, the Multimodal-
ity Intraoperative Brain Mapping system's (e.g., IR image,
UV image, and/or other imaging/data acquisition system)'s
noise characteristics can be collected for better preprocess-
ing of the MBMS images. The noise model developed for
the camera being used also helps design a better tumor
classifier. In one or more embodiments, Camera Calibration
Toolbox for MatlabTM [40, 41] can be used to perform this
step.
A similar calibration can be performed for the photo-
graphic camera and other imaging devices.
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Image Alignment
While camera calibration aligns the images to a certain
extent, in one or more embodiments, accurate pixel-wise
alignment is needed to obtain good training and auto-
classification results. This operation can be non-trivial since
intensity values in each modality image can represent dif-
ferent contrast agents, namely temperature, hydrogen mol-
ecule density, and absorption spectrum, for example. In one
or more embodiments, mutual information is used to provide
alignment criteria for registration. Given two images h and
I2, registration using mutual information comprises finding
a displacement vector field a that deforms Iz so that it aligns
with It. The mutual information Du between images can be
defined as:
D li, lz) = Puli, 
lz)tog 
P.(Il, 12) 
 
d dlz
P4)NY2)
where:
h and I2 represent intensity in each of the images, pu(It,
I2) is the joint probability distribution function of h and Iz
that gives the probability that each of h and Iz falls in any
particular range or discrete set of values specified for that 25
variable, when Iz is deformed by u, p(IJ is the marginal
probability distribution of It falling in any particular range
specified for It, and p(Iz) is the marginal probability distri-
bution of I2 falling in any particular range specified for I2
when Iz is deformed by u. 30
In one or more embodiments, the vector a that maximizes
the mutual information (maximizing of mutual information
registration or MMI registration [123]) is determined/com-
puted. The Iz is then expressed in co-ordinates displaced by
U. 35
It has been shown that this information theoretic criterion
is well suited for alignment of multimodality data [117, 118].
Such a registration has been implemented in MatlabTM using
a 12 parameter amine model, and can be applied to perform
the co-registration of IR, MRI, visual images, as well as and 40
biopsy markers, to common coordinates.
Image-Processing System
One or more embodiments of the invention efficiently
enhance and manipulate the captured camera imagery (e.g.,
IR or UV, or other multi-modal imagery) in near-real time 45
(>5 femtoseconds or >5 picoseconds) using a suite of
efficient image processing tools in MatlabTM (under Red Hat
Linux OSTM). For example, the suite can comprise [17, 18,
19]: (A) Contrast correction/enhancement; (B) Brightness
correction/enhancement; (C) Red Green Blue (RGB) chan- 50
nel histogram equalization for luminance control under a
wide range of lighting conditions; and (E) Edge detection.
B. Auto-Delineation Engine
In one or more embodiments, the auto-delineation engine
employs a supervised learning method/system that operates 55
as follows. The auto-delineation engine first learns incre-
mentally, from human or Al expert-annotated Multimodality
Intraoperative Brain Mapping (e.g., IR image, UV image,
and/or other image and/or data), and visual image pairs, to
distinguish tumor tissue (the training phase). Once trained, 60
the auto-delineation engine is applied to perform auto-
delineation in real time (the operating phase). In the training
phase, the infrared image, MRI image, and visual image can
be supplied along with the expert delineations as inputs. In
the operating phase, IR, UV, MRI, and visual images can 65
supplied as inputs to the classifier and the engine outputs the
delineations.
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Training Phase
In order to train the auto-delineation engine, one or more
embodiments of the invention provide a "reference" data-
base to store and annotate the Multimodality Intraoperative
Brain Mapping (e.g., IR, UV, and/or other image or data) as
well as the visual imagery of the tissue/tumor site. Neuro-
surgeons and/or medical care providers evaluate both the
IR/UV and visual imagery and determine the delineation of
the tumor resection margins. These delineations are graphi-
cally overlaid with the IR/UV and visual imagery and stored
as a separate, "training" set of images (e.g., in the database).
To further improve upon the initial delineations performed
by the neurosurgeons/medical care providers, additional
annotations, based, e.g., on biopsy samples, can be incor-
porated. The imagery delineated by the medical care pro-
viders is inputted as data to a learning method/system (e.g.,
based on Support Vector Machines, SVM). Once trained, the
auto-delineation engine can be tested for accuracy in pre-
dicting the boundaries of brain tumors or other tumors, and
re-validated each time additional training data is supplied.
Although the process is described using IR/UV imagery,
other multi-modal imagery (e.g., MRI, CT, etc.), can also be
used to train the engine).
The method/system based on the Support Vector
Machines (SVM) technique, according to one or more
embodiments, is explained below.
One Class Support Vector Machines
One-class support vector machines construct a classifier
only from a set of labeled positive training samples. The co
registered IR data (x,,,), MRI data (xm,,,), and visual data
(xoP) are arranged in a feature vector x=[x,,,, xoP, x_J. The
training dataset is indexed as x={x1=1, 2, ... , 11, where x,
is the ith observation and 1 denotes the total number of
labeled data points. A feature map is then computed, which
maps the training data into a higher dimensional feature
space F, using a mapping function (D:x—F. Thus, the image
of a training sample x, in x is denoted by (D(x,) in F. Singular
value decomposition (SVD) can be used to generate this
mapping function. Since only the tumor is labeled, the
objective function of one class SVM is denoted as
1 T 1
minWeF,,IeF,beF ~Z W W + v[Y, P; — b~
such that W - (D(x;) 2 b — P;
where W represents the normal vector of the hyper-plane
which represents the decision boundary, b represents the
threshold function, q is the slack variable, and the regular-
ization term v is a user defined parameter which controls the
trade-off and indicates the fraction of samples that should be
accepted by the decision.
This objective function can be minimized (min) over W,
rq, and b using a quadratic programming (QP) optimization
method. The inequality constraint can be imposed using
Lagrange multiplier(s).
FIG. 3 is a block diagram illustrating the auto-delineation
process in the training phase, according to one or more
embodiments of the invention, comprising the following
steps.
Blocks 300a-c represent capturing one or more images of
tissue using a first camera 300a (e.g., UV camera or IR
camera), a second camera (e.g., for visible light) 300b, and
MRI scanner 300c. Cameras 300a-b are not limited to
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particular wavelengths, but typically image at different
wavelengths to provide multi-modal imaging.
Blocks 302a-c represent pre-processing the images, com-
prising de-noising and pre-processing (blocks 302a and
302b) the one or more images taken with the camera 300a 5
and the one or more images taken with the camera 300b, and
bias field correction (block 302c) of the images taken with
the MRI scanner 300c.
Block 304 represents calibration of the camera 300a and
camera 300b. Blocks 306a and 306b represent conversion of 10
the calibrated and pre-processed images obtained from the
camera 300a and camera 300b, respectively, into an entire
data set co-ordinate system. The conversion can enable
matching/comparing/contrasting image points/pixels/ele- 15
ments obtained from each of the MBMS images/data with
the entire data set (e.g., UV image, IR image, visible image,
histology, cellular data) obtained using the MBMS system,
so that the image element/point/pixel in the camera's 300a,
300b image correspondence to an abnormality can be iden- 20
tified (some MBMS data may indicate abnormalities and
some may not). Thus, the image element/pixel from camera
300a, 300b can be replotted in the entire data set co-ordinate
system so that comparison with other MBMS data can be
made (and the any abnormality measured in the image can 25
be identified).
Block 308 represents projecting the bias field corrected
Multimodality Intraoperative Brain Mapping (e.g., MRI,
CT, IR, UV, and/or other image or data) from a three
dimensional (3D) representation into a 2D representation, as 30
well as (optionally) a 4D mathematical image including
predictive modeling.
Blocks 310a-b represent performing a manual delineation
of the images in entire data set co-ordinates (i.e., from
blocks 306a and 306b) to form manually delineated camera 35
images, and Block 310c represents performing a manual
delineation of the MRI images projected in 2D (i.e., from
block 308) to form manually delineated MRI images.
Block 312 represents co-registering the manually delin-
eated images represented in entire data set co-ordinates and 40
the manually delineated MRI image projected in 2D, using
a mutual information method (e.g., as part of image align-
ment as described above), to obtain a co-registered data/
image.
Block 314 represents receiving the co-registered data/ 45
image, and analyzing the co-registered data/image in the
learning based classifier using machine learning (e.g.,
SVM), so that the learning based classifier can learn to
auto-delineate the abnormal tissue in one or more images.
Operating Phase 50
In one or more embodiments, the operating phase com-
prises the following steps.
1. Classifying Data from New Images
Abnormalities in the new images can be classified using
the auto-delineation engine and machine learning trained 55
during the training phase (e.g., using SVM).
2. Noise Reduction
The classification performed using SVM may contain
artifacts (such as multiple disconnected components and
outliers) since it does not take into account the spatial 60
connectivity of the pixels, and thus may be relatively sus-
ceptible to noise. These artifacts can be removed by Markov
Random Field (MRF) modeling [43] of the classifier and
active contour segmentation for the final delineation. This
can be performed by having additional "coherence" terms in 65
the classifier that encourage similar pixel classification for
neighboring pixels.
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3. Active Contour Segmentation
Active contour is a framework for delineating a spatially-
coherent object outline from a noisy 2D image. The seg-
mented image generated in the operating phase can be noisy,
especially at the boundary of the tumor. One or more
embodiments of the invention use Insight Segmentation and
Registration Toolkit (ITKTM) for implementing active con-
tours (e.g., in C++). In order to generate a smooth delinea-
tion of the tumor, active contour framework from the ITKTM
toolkit can be employed. In one or more embodiments,
gradient vector flow (GVF) snakes can be used for the
model.
The GVK snake is an active contour model where the
driving forces are spatial gradients of the image on which the
snake model is applied. A GVK snake can be initialized
based on the image (e.g., MRI) contour mapped to the
classified IR image as described above. The GVF forces,
namely the image gradient, are used to drive the snake,
modeled as a physical object having a resistance to both
stretching and bending, towards the boundaries of the object.
The GVF forces can be calculated by applying generalized
diffusion equations to both components of the gradient of an
image edge map.
A variety of recent image segmentation methods [17, 18,
19, 20, 21] can also be used. Recent techniques for tumor
localization include use Hidden-Markov model and mixture
models. These techniques can be adapted and applied to the
infrared images. Through feed-forward type neural nets [22,
23] and Hopfield attractor neural networks, [24] the image
segments, delivered by the image segmentation methods
above, can be classified as belonging to either tumor or
normal tissue. The neural networks can be trained against
the fully annotated and refined (through biopsies) "refer-
ence" database. For feed-forward type multi-layered percep-
tron systems, a well-established Error-Back-Propagation
method [25, 26] can be used. The Projection Rule or
Pseudoinverse [22, 23, 24, 27], which is a method for storing
highly correlated patterns, can be employed for Hopfield
attractor neural networks. The advantage of attractor net-
works over feed-forward type networks lies in the successful
discrimination between stored stimulation patterns even in
the presence of noise.
In one or more embodiments, the operation phase needs
to be performed in real time during the surgery and therefore
the speed of delineation method is important. Eflicient
methods/systems from the ITK toolkit can be used to
perform this task in real time.
In one or more embodiments, the SVM method/system
can be implemented in MatlabTM (as an example of existing
system) using tools available from the Classification Tool-
box. However, one or more embodiments of the invention
are not limited to the use of a MatlabTM system.
The training phase of the delineation software can be
conducted oflline using the reference database. The operat-
ing phase of performing actual delineations can take place in
real time on a computer connected to the operating room.
Once a surgery is over, manual delineations can be per-
formed on the Multimodality Intraoperative Brain Mapping
(e.g., IR, UV, MRI, CT, and/or other image or data) of the
patient after the surgery. In addition, the cellular and
molecular indications could be identified and integrated in
the system, during the surgery.
FIG. 4 is a block diagram illustrating the auto-delineation
process in the operation phase, according to one or more
embodiments of the invention, comprising the following
steps.
Blocks 400a-c represent capturing one or more images of
tissue using a first camera (e.g., UV or IR camera) 400a, a
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second camera (e.g., for visible light) 400b, and MRI
scanner 400c. Cameras 400a-b are not limited to particular
wavelengths, but typically image at different wavelengths to
provide multi-modal imaging.
Blocks 402a-c represent pre-processing the images, com- 5
prising de-noising and pre-processing (402a and 402b) the
one or more images taken with the camera 400a and the one
or more images taken with the camera 400b, and bias field
correction 402c of the images taken with the MRI scanner
400c. l0
Block 404 represents calibration of the camera 400a and
camera 400b. Blocks 406a and 406b represent conversion of
the calibrated and pre-processed images obtained from the
camera 400a and camera 400b, respectively, into an entire 15
data set co-ordinate system. The conversion can enable
matching/comparing/contrasting image points/pixels/ele-
ments obtained from each of the MBMS images/data with
the entire data set (e.g., UV image, IR image, visible image,
histology, cellular data) obtained using the MBMS system, 20
so that the image element/point/pixel in the camera's 400a,
400b image correspondence to an abnormality can be iden-
tified (some MBMS data may indicate abnormalities and
some may not). Thus, the image element/pixel from camera
400a, 400b can be replotted in the entire data set co-ordinate 25
system so that comparison with other MBMS data can be
made (and the any abnormality measured in the image can
be identified).
Block 408 represents projecting the bias field corrected
MRI image from a 3D into a 2D representation. 30
Block 410 represents performing a manual delineation of
the MRI images projected in 2D (i.e. from Block 408) to
form a manually delineated MRI image.
Block 412 represents co-registering the images repre- 35
sented in entire data set co-ordinates and the manually
delineated MRI image projected in 2D, using a mutual
information method (e.g., as part of image alignment as
described above), to obtain co-registered data.
Block 414 represents receiving the co-registered data in 40
the learning based classifier, wherein the learning based
classifier uses the training data obtained in the training phase
(e.g., FIG. 3) to auto-delineate abnormal regions in the
co-registered data.
Block 416 represents extracting one or more molecular 45
and cellular indicators using the information learned from
the learning based classifier.
Validation of the Overall Approach (Biopsy-Molecular
and Cellular Indicators/Expert Delineations)
In order to perform validation of the overall system, one 50
or more embodiments of the invention can use data obtained
from randomized trials obtained from multiple medical
centers. In one or more embodiments, biopsy marker extrac-
tion can be used for validation. The biopsy marker extraction
in control data can be performed without using the auto- 55
delineation microscope, while surgery on the test subjects
can be performed using a microscope system which shows
tumor hotspots as delineations. The accuracy of biopsy
marker extraction can be compared by T-test.
Validation of Auto-Delineation Method/System 60
The performance of the delineation system, namely, delin-
eation accuracy can be evaluated using validation tech-
niques, including, but not limited to, pattern classification
[43], Cross Validation [44], and Leave one-out validation. In
addition, false alarm (false positive) and miss (true negative) 65
rates can be compared and receiver operating characteristic
(ROC) curves for different estimators can also be compared.
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The parameters of the delineation method/system can be
tuned by using the performance estimates from these tech-
niques.
Additional Considerations
In one or more embodiments, blood artifacts, tissues, and
blood vessels might interfere with the temperature profile
observed from the intraoperative imaging system of the
abnormal tissue. One or more embodiments estimate that
this should not be a significant problem because similar
artifacts are present in the training set as well, and as such,
the learning based classifier is trained to ignore them.
However, in embodiments where these artifacts are a sig-
nificant problem, a semi-automated mode based protocol for
extraction of biopsy markers can be used in which the
neurosurgeon/medical care provider chooses locations of
biopsy markers at his/her discretion. If the classification fails
due to these artifacts, the software can alert the neurosur-
geon/medical care provider. In that case, the neurosurgeon/
medical care provider can switch to a default procedure for
biopsy marker extraction.
In one or more embodiments, the temperature profile at
different stages of the tumor might be different and therefore
might not be sharp at the edges. If this is an obstacle in
training the classifier, fuzzy classification of the tumor tissue
can be performed, assigning probabilities to each pixel in the
MBMS screen/image/data (comprising, e.g., IR, UV, and/or
other images) about the tissue boundary. These probabilities
can be overlaid on the microscope screen and a protocol for
extracting biopsy markers from highly probable sites can be
implemented.
Hardware Environment
FIG. 5 is an exemplary hardware and software environ-
ment 500 used to implement one or more embodiments of
the invention. The hardware and software environment
includes a computer 502 and may include peripherals.
Computer 502 may be a user/client computer, server com-
puter, or may be a database computer. The computer 502
comprises a general purpose hardware processor 504A and/
or a special purpose hardware processor 504B (hereinafter
alternatively collectively referred to as processor 504) and a
memory 506, such as random access memory (RAM). The
computer 502 may be coupled to, and/or integrated with,
other devices, including input/output (I/O) devices such as a
keyboard 514, a cursor control device 516 (e.g., a mouse, a
pointing device, pen and tablet, touch screen, multi-touch
device, etc.) and a printer 528. In one or more embodiments,
computer 502 may be coupled to, or may comprise, a
portable or media viewing/listening device 532 (e.g., an
MP3 player, iPodTM, NookTM, portable digital video player,
cellular device, personal digital assistant, etc.). In yet
another embodiment, the computer 502 may comprise a
multi-touch device, mobile phone, gaming system, internet
enabled television, television set top box, or other internet
enabled device executing on various platforms and operating
systems.
In one embodiment, the computer 502 operates by the
general purpose processor 504A performing instructions
defined by the computer program 510 under control of an
operating system 508. The computer program 510 and/or the
operating system 508 may be stored in the memory 506 and
may interface with the user and/or other devices to accept
input and commands and, based on such input and com-
mands and the instructions defined by the computer program
510 and operating system 508, to provide output and results.
Output/results may be presented on the display 522 or
provided to another device for presentation or further pro-
cessing or action. In one embodiment, the display 522
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comprises a liquid crystal display (LCD) having a plurality
of separately addressable liquid crystals. Alternatively, the
display 522 may comprise a light emitting diode (LED)
display having clusters of red, green and blue diodes driven
together to form full-color pixels. Each liquid crystal or
pixel of the display 522 changes to an opaque or translucent
state to form a part of the image on the display in response
to the data or information generated by the processor 504
from the application of the instructions of the computer
program 510 and/or operating system 508 to the input and
commands. The image may be provided through a graphical
user interface (GUI) module 518. Although the GUI module
518 is depicted as a separate module, the instructions
performing the GUI functions can be resident or distributed
in the operating system 508, the computer program 510, or
implemented with special purpose memory and processors.
In one or more embodiments, the display 522 is integrated
with/into the computer 502 and comprises a multi-touch
device having a touch sensing surface (e.g., track pod or
touch screen) with the ability to recognize the presence of
two or more points of contact with the surface. Examples of
multi-touch devices include mobile devices (e.g., iPhoneTM
Nexus STM, DroidTM devices, etc.), tablet computers (e.g.,
iPadTM, HP TouchpadTM), portable/handheld game/music/
video player/console devices (e.g., iPod TouchTM, MP3
players, Nintendo 3DSTM, P1ayStation PortableTM, etc.),
touch tables, and walls (e.g., where an image is projected
through acrylic and/or glass, and the image is then backlit
with LEDs).
Some or all of the operations performed by the computer
502 according to the computer program 510 instructions
may be implemented in a special purpose processor 504B. In
this embodiment, the some or all of the computer program
510 instructions may be implemented via firmware instruc-
tions stored in a read only memory (ROM), a programmable
read only memory (PROM) or flash memory within the
special purpose processor 504B or in memory 506. The
special purpose processor 504B may also be hardwired
through circuit design to perform some or all of the opera-
tions to implement the present invention. Further, the special
purpose processor 504B may be a hybrid processor, which
includes dedicated circuitry for performing a subset of
functions, and other circuits for performing more general
functions such as responding to computer program 510
instructions. In one embodiment, the special purpose pro-
cessor 504B is an application specific integrated circuit
(ASIC).
The computer 502 may also implement a compiler 512
that allows an application or computer program 510 written
in a programming language such as C, C++, Assembly, SQL,
Python, Prolog, MATLABTM, Ruby, Rails, Haskell, or other
language to be translated into processor 504 readable code.
Alternatively, the compiler 512 may be an interpreter that
executes instructions/source code directly, translates source
code into an intermediate representation that is executed, or
that executes stored precompiled code. Such source code
may be written in a variety of programming languages such
as JavaTM, JavaScriptTM, Per1TM, BasicTM, etc. After comple-
tion, the application or computer program 510 accesses and
manipulates data accepted from I/O devices and stored in the
memory 506 of the computer 502 using the relationships and
logic that were generated using the compiler 512.
The computer 502 can also be comprised in, or connected
to, a Multimodality Brain Mapping System (MBMS) pro-
viding IR, UV, and/or other imaging or data (for example),
either microscopically (using a microscope) and/or endo-
scopically (using an endoscope). For example, the computer
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502 can be comprised in, or connected to, a scope. In one or
more embodiments, one or more of the processors 504
implement the learning method/system or methods of imag-
ing or identifying abnormal tissue according to one or more
5 embodiments of the invention.
The computer 502 also optionally comprises an external
communication device such as a modem, satellite link,
Ethernet card, or other device for accepting input from, and
providing output to, other computers 502.
10 In one embodiment, instructions implementing the oper-
ating system 508, the computer program 510, and the
compiler 512 are tangibly embodied in a non-transitory
computer-readable medium, e.g., data storage device 520,
which could include one or more fixed or removable data
15 storage devices, such as a zip drive, floppy disc drive 524,
hard drive, CD-ROM drive, tape drive, etc. Further, the
operating system 508 and the computer program 510 are
comprised of computer program 510 instructions which,
when accessed, read and executed by the computer 502,
20 cause the computer 502 to perform the steps necessary to
implement and/or use the present invention or to load the
program of instructions into a memory 506, thus creating a
special purpose data structure causing the computer 502 to
operate as a specially programmed computer executing the
25 method steps described herein. Computer program 510
and/or operating instructions may also be tangibly embodied
in memory 506 and/or data communications devices,
thereby making a computer program product or article of
manufacture according to the invention. As such, the terms
30 "article of manufacture," "program storage device," and
"computer program product," as used herein, are intended to
encompass a computer program accessible from any com-
puter readable device or media. In one or more embodi-
ments, computer 502 may be coupled to, or may comprise,
35 or be integrated in, an imaging system 530 (e.g., optics,
microscope, microscope optics, camera). For example, the
processing (e.g., the machine learning) can be performed in
the imaging system 530.
Of course, those skilled in the art will recognize that any
40 combination of the above components, or any number of
different components, peripherals, and other devices, may be
used with the computer 502.
FIG. 6 schematically illustrates a typical distributed com-
puter system 600 using a network 604 to connect client
45 computers 602 to server computers 606. A typical combi-
nation of resources may include a network 604 comprising
the Internet, LANs (local area networks), WANs (wide area
networks), SNA (systems network architecture) networks, or
the like, clients 602 that are personal computers or work-
50 stations (as set forth in FIG. 5), and servers 606 that are
personal computers, workstations, minicomputers, or main-
frames (as set forth in FIG. 5). However, it may be noted that
different networks such as a cellular network (e.g., GSM
[global system for mobile communications] or otherwise), a
55 satellite based network, or any other type of network may be
used to connect clients 602 and servers 606 in accordance
with embodiments of the invention.
A network 604 such as the Internet connects clients 602
to server computers 606. Network 604 may utilize ethernet,
60 coaxial cable, wireless communications, radio frequency
(RF), etc. to connect and provide the communication
between clients 602 and servers 606. Clients 602 may
execute a client application or web browser and communi-
cate with server computers 606 executing web servers 610.
65 Such a web browser is typically a program such as MICRO-
SOFT INTERNET EXPLORERTM, MOZILLA FIRE-
FOXTM, OPERATM, APPLE SAFARITM, GOOGLE
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CHROMETM, etc. Further, the software executing on clients
602 may be downloaded from server computer 606 to client
computers 602 and installed as a plug-in or ACTIVEXTM
control of a web browser. Accordingly, clients 602 may
utilize ACTIVEXTM components/component object model
(COM) or distributed COM (DCOM) components to pro-
vide a user interface on a display of client 602. The web
server 610 is typically a program such as MICROSOFT'S
INTERNET INFORMATION SERVERTM
Web server 610 may host an Active Server Page (ASP) or
Internet Server Application Programming Interface (ISAPI)
application 612, which may be executing scripts. The scripts
invoke objects that execute business logic (referred to as
business objects). The business objects then manipulate data
in database 616 through a database management system
(DBMS) 614. Alternatively, database 616 may be part of, or
connected directly to, client 602 instead of communicating/
obtaining the information from database 616 across network
604. When a developer encapsulates the business function-
ality into objects, the system may be referred to as a
component object model (COM) system. Accordingly, the
scripts executing on web server 610 (and/or application 612)
invoke COM objects that implement the business logic.
Further, server 606 may utilize MICROSOFT'STM Transac-
tion Server (MTS) to access required data stored in database
616 via an interface such as ADO (Active Data Objects),
OLE DB (Object Linking and Embedding DataBase), or
ODBC (Open DataBase Connectivity).
Generally, these components 600-616 all comprise logic
and/or data that is embodied in/or retrievable from device,
medium, signal, or carrier, e.g., a data storage device, a data
communications device, a remote computer or device
coupled to the computer via a network or via another data
communications device, etc. Moreover, this logic and/or
data, when read, executed, and/or interpreted, results in the
steps necessary to implement and/or use the present inven-
tion being performed.
Although the terms "user computer", "client computer",
and/or "server computer" are referred to herein, it is under-
stood that such computers 602 and 606 may be interchange-
able and may further include thin client devices with limited
or full processing capabilities, portable devices such as cell
phones, notebook computers, pocket computers, multi-touch
devices, and/or any other devices with suitable processing,
communication, and input/output capability.
Embodiments of the invention are implemented as a
software application on a client 602 or server computer 606.
Further, as described above, the client 602 or server com-
puter 606 may comprise a thin client device or a portable
device that has a multi-touch-based display.
Of course, those skilled in the art will recognize that any
combination of the above components, or any number of
different components, peripherals, and other devices, may be
used with computers 602 and 606.
Possible Modifications and Variations
One or more embodiments of the invention further com-
prise growing the database of training data over time and/or
linking a plurality of microscopes together through cloud
computing. This data network can create metadata that can
be used to achieve significantly more precise behavioral
pattern recognition of brain malignancies based on hundreds
of thousands of cases operated on by different surgeons with
different levels of expertise across the globe.
FIG. 6 further illustrates a cloud and/or parallel comput-
ing system, according to one or more embodiments, wherein
the data obtained from the images captured in a plurality of
microscopes 618 is shared over the network 604, so that the
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machine learning learns to identify one or more abnormali-
ties from the data obtained from a plurality of microscopes
618 obtaining images during surgical (or other) procedures
on a plurality of different patients/cases. Thus, the machine
5 learning can learn from the data obtained from different
surgeries. The machine learning can be implemented on a
plurality of computers in the system, e.g., working in
parallel and/or each performing different processes.
Logical Flow for Identifying Abnormal Cells
10 FIG. 7 is a flowchart illustrating a method of identifying
abnormal cells in a patient/tissue, according to one or more
embodiments of the invention.
Block 700 represents obtaining training data from first
data or one or more first images of tissue, wherein one or
15 more abnormal regions and one or more normal regions (of
a patient's tissue or of one or more tissues) are identified.
The training data can comprise human or Al delineations/
classification of the abnormal regions in the one or more first
images.
20 Block 702 represents receiving/capturing one or more
second images of the tissue, the second images captured at
a later time than the one or more first images/first data,
and/or using a different imaging technique/system 630 than
was used to capture the one or more first images, and/or
25 using a Multimodality Brain Mapping System (MBMS)
comprising IR, UV, and/or other imaging system or data
acquisition system.
Block 704 represents generating, using machine learning,
one or more viewable indicators identifying one or more
so abnormal cells and/or normal cells in the one or more second
images. The training data can be inputted to, and the
machine learning method/system can be implemented on, a
machine such as computer 502/606 (e.g., in a machine
learning unit/processor of the computer). The machine
35 learning method/system can be trained using the training
data to identify one or more biological cells in the second
image as abnormal or normal (e.g., trained to distinguish one
or more abnormal cells from one or more normal cells of the
tissue shown in the second image).
40 The machine learning can use pattern recognition or
recognize regularities or correlations in data obtained from
the first and second images. While the pattern recognition
system can be trained from labeled "training" data (super-
vised learning), other methods/systems can also be used to
45 discover previously unknown patterns (unsupervised learn-
ing), or a combination of supervised and unsupervised
learning can be used (semi-supervised learning). The learn-
ing method/system can use a pattern recognition method/
system to predict a pattern of growth of, and/or location of,
50 the one or more abnormal cells in the second image.
The one or more viewable indicators can be generated in
real time or dynamically (e.g., in less than 5 picoseconds) as
the image is formed/captured.
Block 706 represents using the learning method/system in
55 an application, for example with a microscope. The learning
method/system can be implemented on one or more proces-
sors or computers integrated with the microscope or con-
nected to the microscope, e.g., wirelessly or via a wired
network connection (e.g., in a cloud computing based sys-
60 tern). Thus, the indicators can be viewable on the one or
more second images formed in a (e.g., digital) microscope/
endoscope, (e.g., digital) camera, (e.g., digital) endoscope,
or other imaging system/MBMS. The second image can be
an image captured during a surgical procedure on the tissue
65 in a patient, and the one or more first images can be images
(e.g., MRI, CT, Positron Emission Tomography (PET)) as
part of the MBMS-system captured prior to the surgical
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procedure. For example, metadata obtained from the one or
more first images can be brought together to enable analysis
of the image formed in a microscope/endoscope in real time
and allow the artificial intelligence (e.g., provided by the
learning method/system) of the microscope reach out to all
aspects of the data in pre-op, intra-, and post-op (past
surgeries), and in the intra-operative data set. This can help
surgeons not only differentiate between normal and abnor-
mal tissue but also help the device teach itself so the
microscope/endoscope becomes a member of surgical team
rather than a device. The technology can inform surgeons
where to look at for diseased tissue, which has never been
done and is revolutionary. The technology can also inform
medical care providers what adjunctive therapy should be
applied and where, what would be the predictive outcome of
the surgery based on the past numbers of cases, and what
should be anticipated in the future. Current solutions include
use of intra operative CT, MRI, and optical (visible, ultra-
violet, near infrared, infrared, etc.) as a single modality. In
this regard, integration of multimodality imaging system/
MBMS with artificial intelligence and software that helps
pattern recognition has not been attempted.
The learning method/system can comprise a support vec-
tor machine (SVM). For example, the SVM can analyze the
training data and recognize patterns or correlations in the
training data, wherein the training data is classified and
subjected to a regression analysis. For example, given a set
of training examples, each labeled as being normal or
abnormal (e.g., cancerous or non-cancerous), a support
vector training method/system can build a model that
assigns new examples as being abnormal or normal (e.g., a
non-probabilistic binary linear classifier). The SVM can
perform a non-linear classification using a kernel method,
mapping the inputs (training data or new data) into high-
dimensional feature spaces.
FIG. 8 is a flowchart illustrating a method for identifying
one or more abnormal cells in an image of a patient's tissue
(e.g., that could be implemented by a SVM). The method
can comprise the following steps.
Block 800 represents receiving and/or capturing one or
more first images of one or more first tissues (e.g., a thermal
or UV image) of one or more first patients. The first patients
can comprise different patients, for example.
Block 802 represents calibrating the one or more first
images, if necessary. The step can comprise converting the
first images to a same entire data set co-ordinate system
and/or co-registering the first images. For example, the step
can comprise registering multimodal images/first data
obtained from two or more of the following: biopsy, Infrared
Imaging, Diffusion Tensor Imaging (DTI), Computed
Tomography (CT), Magnetic Resonance Imaging (MRI),
Brain Mapping Ultrasound, cellular, molecular and genomic
data, and Functional MRI (FMRI) to form a registered image
and/or patient data. In one or more embodiments, the
registering can achieve geometrical correspondence
between the images, or geometric alignment/overlaying of
the images to compare corresponding regions in each image
volume/area, e.g., such that from the coordinates of a point
in one image, the coordinates of the geometrically corre-
sponding point in each of the other images can be obtained.
For example, the registering can be such that anatomically
identical points can be located and compared in each of the
images. The registering can be such that the features mea-
sured in each of the images are visible in one image.
Block 804 represents identifying one or more abnormal
regions and one or more normal regions of the one or more
first tissues shown in the first images (e.g., using expert
20
delineation provided by a medical care provider). The one or
more abnormal regions can be identified in at least two
co-registered first images and/or patient data (e.g., showing
different properties of the tissue). The identification can be
5 improved using state-of-the-art computer simulations (e.g.,
[121]) and/or predictive oncology (e.g., [122]) which is
advancing field. The expert delineation can be inputted into
a database on a computer or inputted/marked by a user
(medical image) on an image in a computer. A training
l0 database can be provided wherein one or more image
elements in the one or more first images or registered image
are identified by a medical care provider as abnormal or
normal.
15 Block 806 represents representing the identified abnor-
mal/normal (e.g., cancerous/non-cancerous) regions with
feature vectors in a feature space (e.g., as defined and
performed by a support vector machine). A feature can be
any distinctive aspect, quality, or characteristic of abnormal/
20 normal regions, and a feature vector can be an n-dimensional
vector of numerical or symbolic (e.g., color) features that
represent the abnormal or normal regions. For example, the
feature vector comprising the combination of d features can
be represented as a d-dimensional column vector. When
25 representing images, the feature values might correspond to
the pixels or voxels of an image. The feature space can be
the vector space associated with/defined by these feature
vectors.
The step 806 can comprise representing the abnormal
so regions of the first images/registered image with first feature
vectors defining first coordinates/points/regions in a feature
space, and representing the normal regions of the first image
with second feature vectors defining second coordinates/
points/regions in the feature space (e.g., the abnormal and
35 normal regions can be represented as points in the feature
space, as in a scatter plot or graph). The feature space can be
selected such that at least some of the first coordinates/points
and at least some of the second coordinates/points are on
opposite sides of a hyper-plane in the feature space. For
40 example, at least some of the first coordinates can be on a
first side of the hyper-plane and at least some of the second
coordinates can be on a second side of the hyper-plane. The
step can comprise finding the appropriate feature space and
optimizing the co-ordinates of the hyper-plane in the feature
45 space (e.g., using regression analysis). The step can further
comprise optimizing the hyper-plane using error correction
methods/systems using the validation techniques discussed
above.
Block 808 represents receiving (and optionally capturing)
50 one or more second images of one or more second tissues of
a second patient (the second patient can be the same as one
or more of the first patients, or can be a different patient from
one or more of the first patients). The one or more second
tissues can be the same as one or more of the first tissues, or
55 different from the first tissues. The second image can com-
prise an image of the same or a different region of the tissue
imaged with the one or more first images. The second
images (e.g., comprising an optical image) can be captured
in an imaging system (e.g., a camera, e.g., during a surgical
60 procedure) and/or using a MBMS. The first image and
second images can show different properties/characteristics
of the tissue. The step can comprise co-registering/calibrat-
ing the images if necessary.
Block 810 represents mapping one or more image
65 regions/elements, comprising one or more regions/pixels/
voxels of the one or more second images, to one or more
image coordinates/points/regions in the feature space, so
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that the one or more image regions are represented as feature
vectors (image feature vectors) in the feature space.
Block 812 represents classifying the image feature vectors
or image coordinates in the feature space (e.g., using SVM).
The step can comprise classifying one or more of the image
coordinates as one or more abnormal coordinates or normal
coordinates depending on one or more factors, including
which side of the hyper-plane the one or more image
co-ordinates lie, and/or proximity of the one or more image
coordinates to the first abnormal coordinates and/or the
hyper-plane. For example, the image region can be classified
as an abnormal image region if the image region is mapped
to one or more of the abnormal coordinates according to the
mapping (i.e., closer to the first coordinates and/or on the
first side of the hyper-plane); such image region can be
classified as a normal image region if the image region is
mapped to one or more of the normal coordinates according
to the mapping (i.e., closer to the second coordinates and/or
on the second side of the hyper-plane). FIG. 9 illustrates an
example of a feature space having a first dimension and a
second dimension, illustrating the first feature vector 900
defining first coordinate 902, the second feature vector 904
defining second coordinate 906, image feature vector 908
defining abnormal coordinate 910, and hyper-plane 912.
Block 814 represents forming the one or more indicators
to indicate the one or more cells as abnormal if the one or
more cells are in the abnormal image region, and/or forming
the one or more indicators to indicate the one or more cells
as normal if the one or more cells are in the normal image
region. The forming can comprise overlaying, integrating, or
compositing the second image with the indicators in the
display of the imaging system. The indicators can be pro-
vided in a visually distinguishable manner, for example
using colors, intensity, contrast, highlighting, flashing, or
sound, etc.
Block 816 represents using the indicators in an applica-
tion, for example during a surgical procedure. For example,
the second image can comprises an optical image captured
during a surgical procedure on a patient, and the one or more
viewable indicators can enable the abnormal region to be
surgically removed from the patient, during the surgical
procedure, with increased precision by reducing damage to
normal tissue.
Steps 700-706 and 800-816 can be implemented in one or
more processors (as described herein) interfaced/coupled to
an imaging system 530, such as a micro scope/endoscope. In
one or more embodiments, software implementing the meth-
od(s) of steps 800-816 can be converted to a C++ standalone
library and run as a standalone binary on a variety of
platforms including Redhat LinuxTM, Mac OS XTM and
Windows VistaTM, for example.
Furthermore, steps 800-816 or 800-806 can be imple-
mented using a plurality of microscopes/surgical micro-
scopes/imaging systems. In one or more embodiments, the
microscopes 718 can be connected to learn, share, and
access data from one another, e.g., over a network 704 (as
illustrated in FIG. 6) using cloud computing or parallel
computing. Multi-central parallel computing and machine
learning can be provided. Thus, FIGS. 5-8 illustrate the
method can comprise obtaining the one or more first images
of one or more patients captured with one or more first
microscopes 618; obtaining the second image of a second
patient captured with a second microscope 618, wherein the
second patient is different from the one or more patients;
connecting the first and second microscopes using a cloud
and/or parallel computing system 602, 606, that provides the
machine learning; and wherein the training data obtained
22
from the one or more first images captured in the first
microscopes 618 is shared so that the machine learning
learns from the training data to identify the abnormality in
the second image.
5 As used throughout this disclosure, an abnormality, one or
more abnormalities, one or more abnormal cells, and one or
more abnormal regions can comprise, but are not limited to,
cancer, one or more cancerous regions or one or more
cancerous cells, one or more tumors, one or more epileptic
io regions or one or more epileptic cells, and/or one or more
arteriovenous malformations in a patient/one or more tissues
of a patient. The patient can comprise an animal or human
patient and the tissue/cells can comprise animal, human, or
plant tissue/cells. Thus, one or more embodiments of the
15 invention can be extended to identifying disease generally,
e.g., identifying diseased regions/tissue/cells from non-dis-
eased regions/tissue/cells that do not have the disease. One
or more embodiments of the invention can identify regions/
cells that are not regular, do not conform to a standard type,
20 that are not natural, that are not normal, or that are not
healthy.
As used in this disclosure, one or more scopes can
comprise, but are not limited to, one or more microscopes,
one or more endoscopes, one or more cameras, and/or one
25 or more instruments used to image (e.g., using optical or
other wavelengths, as used in medical imaging systems
and/or MBMS). A Multimodality Brain Mapping System
(MBMS) according to one or more embodiments of the
invention can include, but is not limited to IR, UV, MRI, CT,
30 Ultrasound images, or other images, as well as molecular
data, cellular data, genomic data, and patient medical data.
Advantages and Improvements
Benefits of a Multimodality Brain Mapping System
(MBMS) (i.e., a System Obtaining IR, UV, MRI, CT,
35 Ultrasound, or Other Images, Image as Well as Molecular,
Cellular and Genomic and Patient Medical Data)
Intra-operative magnetic resonance imaging (MRI) and
frameless stereotaxis are currently employed as adjuncts to
tumor removal. Intra operative MRI suffers from the fact
40 that malignant brain tumors exhibit variable contrast
enhancement and therefore portions of the tumor may
remain hidden during the surgical procedure. Frameless
stereotactic techniques suffer from the inevitability of brain
shift, as portions of the tumor are removed during surgery.
45 PET scans cannot be used intraoperatively. Ultrasound, once
the resection starts, is limited by signal artifacts caused by
blood and surgical trauma at the resection margin [1, 11].
Therefore, there is a pressing need for identifying the
margins of an invasive tumor, in order to ensure complete
5o resection. Although fluorescence dyes, time resolved laser
induced fluorescence spectroscopy (tr-LIFS), and laser-in-
duced fluorescence of a photosensitizer (hematoporphyrin
derivative) have also have been used to delineate various
tumors of lung, bladder, colon and brain from the surround-
55 ing normal tissue, they have not yet found clinical applica-
tion for malignant brain tumors [1, 2, 3, 4, 6, 7, 8, 9, 10, 12].
In the specific case of photosensitizers, the photosignaling is
dependent on the injection of specific light sensitive com-
pounds. The procedure is invasive and in the case of tr-LIFS,
60 the data acquisition takes a very long time, penetration depth
is limited, and the data are only acquired from the very tip
of the optical probe. MBMS could use temperature and other
gradients on the other hand, due to the change in metabolic
pathways in patients with brain tumors, can be detected by
65 IR, UV, or other imaging techniques.
MBMS is a novel technique that has a powerful potential
for identifying the margins of intraparenchymal primary and
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metastatic brain tumors. Previous published data have indi-
cated that metastatic brain tumors, including intracortical
melanoma, exhibited hyperthermic profiles [50, 51, 52].
Interestingly, thermography has been used to investigate
melanoma and consistently reported that it was hyperther- 5
mic. The first experimentation on cutaneous malignant
melanoma was conducted in 1964 and revealed a hyperther-
mic profile with respect to surrounding normal tissue [61].
Subsequent studies revealed similar findings. These studies
have established that thermography is a reliable detection io
and prognostic [85] tool in cutaneous melanoma diagnosis.
In addition to the dermatological application of thermal
imaging, corneal and ocular malignant melanomas have also
been detected using IR thermography. Like cutaneous mela-
nomas and the tumor in [123], these tumors displayed a 15
hyperthermic profile with respect to the surrounding normal
tissue [115].
This new modality can provide important real-time imag-
ing information about the tumor location that is not com-
promised by brain shift, resulting in better intra-operative 20
tumor localization and improving the chance of complete
resection. Thus intraoperative use of IR imaging can enable
neurosurgeons/medical care providers to more completely
delineate brain tumors or other abnormalities such as epi-
leptic regions. Also, in terms of image contrast, new 25
advances in the field of optical imaging and thennoencepha-
lography have made it possible to view the organization of
the tissue with respect to its metabolism and blood flow
profile. The intraoperative use of an infrared camera can
detect the more metabolically active leading edge of the 30
tumor, thereby allowing for a more thorough resection.
Previous experimental studies have demonstrated the capa-
bility of the infrared imaging technique in enhancing the
contrast of human gliomas and tumor margins [1, 7, 8] and
can be helpful in identifying remnants of the glioma/abnor- 35
malities.
Thus, integration of technology such as MBMS into the
operating room of the future can improve the efficiency of
tumor resection. Tumor resection has been reported to
increase patient survival [120]. Such an improvement would 40
contribute to a higher quality of life for patients, bringing the
patients back to the workforce and possibly reducing reha-
bilitation time and costs, thus making a significant impact on
the economical recovery of individuals and the society.
Advantages of the Auto-Delineation System According to 45
One or More Embodiments
Primary and secondary brain tumors affect over 200,000
individuals per year in the United States alone with a high
mortality rate and over $49,242 in average direct medical
expenses [116, 53]. This does not include rehabilitation costs 50
which will increase dramatically over the years. For patients
diagnosed with brain tumors, the likelihood of significant
reduction in income increases threefold, since more than 2/3
of them are unable to go back to the workforce [119]. 47%
of these patients incur credit card debt, with 7.2% declaring 55
bankruptcy, 15% resorting to a second or third mortgage,
and 8.5% caching into their retirement or life insurance
savings. Thus, brain tumors put a significant financial strain
on the US economy and health care system.
Recent advancements in MRI and CT scan technology 60
offer higher resolution and precision of brain images [107].
However, determination of pre- and post-resection volumes
of tumors using MRI are of limited intra-operative value
since these scans are typically not performed in real time
during the neurosurgery. In most cases, these imaging 65
modalities are still non-dynamic with respect to intra-opera-
tive changes of brain topography and tumor dimensions due
ME
to intra-operative debulking and manipulations. While the
bulk of the tumor can be removed by visual inspection, an
accurate visual assessment of tumor margins is extremely
difficult because the tumor margins riddled by cancerous
cells.
Moreover, existing intraoperative imaging technologies
have inherent limitations in providing real-time intraopera-
tive feedback about the completeness of the resection. For
example, the use of intraoperative point-by-point biopsy can
be time consuming and non-objective, since it is a hit and
miss process.
Intraoperative multi-modality imaging can be helpful in
resolving these issues, and thus in increasing the extent of
resection. One or more embodiments of the invention lever-
age MBMS in the operating room, both by a real-time
visualization of the MBMS image of the brain in alignment
with the visible light view, and by employing a tumor
auto-delineation software that identifies tumor margins
based on the temperature profile of the brain, using modern
machine learning techniques. Such delineations can be made
available in the real time to the surgeons (neurosurgeons)
intraoperatively. Moreover, one embodiments of the inven-
tion can assess the margin as well as biological nature of the
tumors.
As a result, the auto-delineating system according to one
or more embodiments of the invention can lead to complete
tumor resection by providing a precise and real time mul-
timodality imaging analysis feedback to neurosurgeons/
medical care providers based on ITI, CT, MRI, visible
images and biopsy/cellular and or molecular indicators. This
system can provide surgeons (e.g., neurosurgeons) with a
tool that could dramatically contribute to the surgical pre-
cision and intra-operative decision making. This in turn will
contribute to lower mortality and morbidity, which could
decrease in direct and indirect healthcare costs. Furthermore,
the technology can be integrated into the intra-operative
microscopes.
In addition, high resolution imaging developed in ultra-
violet, visible and near infrared spectral range has wide
range of applications in NASA missions as well as com-
mercial and defense applications. However, while the Smart
Microscope/endoscope can be used for future Space appli-
cations, the immediate benefits include integrating technolo-
gies from many different NASA multispecialty groups (e.g.,
artificial intelligence (AI), mathematical modeling, imag-
ing). This is a clear dual use application of currently existing
NASA technologies with significant medical impact on the
surgical outcome of complicated brain surgery cases, which
could save billions of dollars in healthcare costs in the US
alone.
CONCLUSION
This concludes the description of the preferred embodi-
ment of the present invention. The foregoing description of
the preferred embodiment of the invention has been pre-
sented for the purposes of illustration and description. It is
not intended to be exhaustive or to limit the invention to the
precise form disclosed. Many modifications and variations
are possible in light of the above teaching. It is intended that
the scope of the invention be limited not by this detailed
description, but rather by the claims appended hereto.
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What is claimed is:
1. A system, comprising one or more scopes coupled to
one or more processors, wherein:
the one or more processors:
obtain training data from one or more first images
and/or first data, wherein one or more abnormal
regions and one or more normal regions are identi-
fied;
receive a second image captured by one or more of the
scopes at a later time than the one or more first
images and/or first data and/or captured using a
different imaging technique; and
generate, using machine learning trained using the
training data, one or more viewable indicators iden-
tifying one or more abnormalities in the second
32
image, wherein the one or more viewable indicators
are generated in real time as the second image is
formed; and
one or more of the scopes display the one or more
5 viewable indicators on the second image.
2. The system of claim 1, wherein:
one or more of the processors comprise one or more
multi-modality data processors; and
the multi-modality data processors register at least two of
l0 the first images and/or first data obtained from biopsy,
Infrared Imaging, Ultraviolet Imaging, Diffusion Ten-
sor Imaging (DTI), Computed Tomography (CT), Mag-
netic Resonance Imaging (MRI), Brain Mapping Ultra-
15 sound, cellular data, molecular data, genomic data,
optical imaging, and Functional MRI (FMRI), to form
a registered image and/or patient data; and
one or more of the processors receive input that identifies
or marks the one or more abnormal and one or more
20 normal regions in the registered image and/or patient
data.
3. The system of claim 1, wherein the one or more first
images comprise a pre-operative image, an intra-operative
image, and/or a post operative image of one or more
25 patients.
4. The system of claim 1, wherein:
the one or more scopes comprise one or more first scopes
and a second scope; and
the one or more first scopes capture the one or more first
30 images of one or more patients and the second scope
captures the second image of a different patient.
5. The system of claim 4, further comprising:
a cloud and/or parallel computing system wherein the
training data obtained from the one or more first images
35 captured in the one or more first scopes is shared so that
the machine learning learns from the training data to
identify the one or more abnormalities in the second
image of the different patient.
6. The system of claim 1, wherein the processors that
40 predict growth of the one or more abnormalities in the
second image from predictive modeling of, and/or pattern
recognition in, the training data.
7. The system of claim 1, wherein one or more of the
processors:
45 represent the one or more abnormal regions with first
feature vectors defining first coordinates in a feature
space;
represent the one or more normal regions with second
feature vectors defining second coordinates in the fea-
50 ture space, wherein the feature space is selected such
that at least some of the first coordinates and at least
some of the second coordinates are on opposite sides of
a hyper-plane in the feature space;
map an image region of the second image to one or more
55 image coordinates in the feature space;
classify one or more of the image coordinates as one or
more abnormal coordinates depending on one or more
factors, including:
which side of the hyper-plane the one or more image
60 coordinates lie; and/or
proximity of the one or more image coordinates to the
first coordinates and/or the hyper-plane; and
indicate the image region as an abnormal image region if
the image region is mapped to one or more of the
65 abnormal coordinates according to the map.
8. The system of claim 1, wherein the one or more
processors implement a support vector machine.
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9. The system of claim 1, wherein:
one or more of the scopes comprise one or more micro-
scopes and/or one or more endoscopes including an
optical imaging system for capturing the second image;
and
the second image comprises an optical image.
10. The system of claim 1, wherein:
one or more of the one or more scopes comprise a surgical
scope capturing the second image during a surgical
procedure on a patient, and
the one or more viewable indicators enable the one or
more abnormalities to be surgically removed from the
patient, during the surgical procedure, with increased
precision by reducing damage to normal tissue.
11. A method for identifying one or more abnormalities in
an image, comprising:
obtaining training data from one or more first images
and/or first data, wherein one or more abnormal regions
and one or more normal regions in the one or more first
images and/or first data are identified;
receiving a second image of the tissue captured at a later
time than the one or more first images and/or first data
and/or using a different imaging technique; and
generating, using machine learning trained using the
training data, one or more viewable indicators identi-
fying one or more abnormalities in the second image,
wherein the one or more viewable indicators are gen-
erated in real time as the second image is formed.
12. The method of claim 11, further comprising:
registering at least two of the first images and/or first data
obtained from biopsy, Infrared Imaging, Ultraviolet
Imaging Diffusion Tensor Imaging (DTI), Computed
Tomography (CT), Magnetic Resonance Imaging
(MRI), Brain Mapping Ultrasound, cellular data,
molecular data, and genomic data, optical imaging, and
Functional MRI (FMRI), to form a registered image
and/or patient data; and
receiving input that identifies or marks the one or more
abnormal and one or more normal regions in the
registered image and/or patient data.
13. The method of claim 12, wherein the one or more first
images comprise a pre-operative image and/or a post opera-
tive image of a patient.
14. The method claim 11, further comprising:
obtaining the one or more first images of one or more
patients captured with one or more first scopes; and
obtaining the second image of a different patient captured
with a second scope.
34
15. The method of claim 14, further comprising connect-
ing the one or more first scope and the second scope using
a cloud and/or parallel computing system wherein the train-
ing data obtained from the one or more first images captured
5 in the one or more first scopes is shared so that the machine
learning learns from the training data to identify the one or
more abnormalities in the second image of the different
patient.
16. The method of claim 11, wherein the machine learning
10 predicts growth of the one or more abnormal cells in the
second image from predictive modeling of, and/or pattern
recognition in, the training data.
17. The method of claim 11, further comprising:
15 representing the one or more abnormal regions with first
feature vectors defining first coordinates in a feature
space;
representing the one or more normal regions with second
feature vectors defining second coordinates in the fea-
20 ture space, wherein the feature space is selected such
that at least some of the first coordinates and at least
some of the second coordinates are on opposite sides of
a hyper-plane in the feature space;
mapping an image region of the second image to one or
25 
more image coordinates in the feature space;
classifying one or more of the image coordinates as one
or more abnormal coordinates depending on one or
more factors, including:
which side of the hyper-plane the one or more image
30 coordinates lie; and/or
proximity of the one or more image coordinates to the
first coordinates and/or the hyper-plane; and
indicating the image region as an abnormal image region
if the image region is mapped to one or more of the
35 abnormal coordinates according to the mapping.
18. The method of claim 11, wherein the machine learning
comprises a support vector machine.
19. The method of claim 11, wherein:
the second image comprises an optical image captured
40 during a surgical procedure on a patient, and
the one or more viewable indicators enable the one or
more abnormalities to be surgically removed from the
patient, during the surgical procedure, with increased
precision by reducing damage to non-cancerous tissue.
45 
20. The method of claim 11, further comprising capturing
the second image with a microscope, endoscope, and/or
camera.
